4cre: Difference between revisions

← Older edit

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
 ==Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design==
-<StructureSection load='4cre' size='340' side='right' caption='[[4cre]], [[Resolution|resolution]] 1.73&Aring;' scene=''>
+<StructureSection load='4cre' size='340' side='right'caption='[[4cre]], [[Resolution|resolution]] 1.73&Aring;' scene=''>
 == Structural highlights ==
-<table><tr><td colspan='2'>[[4cre]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CRE OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CRE FirstGlance]. <br>
+<table><tr><td colspan='2'>[[4cre]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CRE OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4CRE FirstGlance]. <br>
-</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MVN:6-CHLORO-4-METHYL-1H-QUINOLIN-2-ONE'>MVN</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
+</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.73&#8491;</td></tr>
-<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4cr5|4cr5]], [[4cr9|4cr9]], [[4cra|4cra]], [[4crb|4crb]], [[4crc|4crc]], [[4crd|4crd]], [[4crf|4crf]], [[4crg|4crg]]</td></tr>
+<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=MVN:6-CHLORO-4-METHYL-1H-QUINOLIN-2-ONE'>MVN</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
-<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Coagulation_factor_XIa Coagulation factor XIa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.27 3.4.21.27] </span></td></tr>
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4cre FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cre OCA], [https://pdbe.org/4cre PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4cre RCSB], [https://www.ebi.ac.uk/pdbsum/4cre PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4cre ProSAT]</span></td></tr>
-<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4cre FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cre OCA], [http://pdbe.org/4cre PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4cre RCSB], [http://www.ebi.ac.uk/pdbsum/4cre PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4cre ProSAT]</span></td></tr>
 </table>
-== Disease ==
-[[http://www.uniprot.org/uniprot/FA11_HUMAN FA11_HUMAN]] Defects in F11 are the cause of factor XI deficiency (FA11D) [MIM:[http://omim.org/entry/612416 612416]]; also known as plasma thromboplastin antecedent deficiency or Rosenthal syndrome. It is a hemorrhagic disease characterized by reduced levels and activity of factor XI resulting in moderate bleeding symptoms, usually occurring after trauma or surgery. Patients usually do not present spontaneous bleeding but women can present with menorrhagia. Hemorrhages are usually moderate.<ref>PMID:2813350</ref> <ref>PMID:1547342</ref> <ref>PMID:7888672</ref> <ref>PMID:7669672</ref> <ref>PMID:9401068</ref> <ref>PMID:9787168</ref> <ref>PMID:10027710</ref> <ref>PMID:10606881</ref> <ref>PMID:11895778</ref> <ref>PMID:15026311</ref> <ref>PMID:15180874</ref> <ref>PMID:15953011</ref> <ref>PMID:16607084</ref> <ref>PMID:18005151</ref> <ref>PMID:21668437</ref> <ref>PMID:21457405</ref> <ref>PMID:22016685</ref> <ref>PMID:22322133</ref> <ref>PMID:21999818</ref> <ref>PMID:22159456</ref>
-== Function ==
-[[http://www.uniprot.org/uniprot/FA11_HUMAN FA11_HUMAN]] Factor XI triggers the middle phase of the intrinsic pathway of blood coagulation by activating factor IX.
 <div style="background-color:#fffaf0;">
 == Publication Abstract from PubMed ==
@@ Line 24: / Line 19: @@
 ==See Also==
-*[[Factor XIa|Factor XIa]]
+*[[Factor XIa 3D structures|Factor XIa 3D structures]]
 == References ==
 <references/>
 __TOC__
 </StructureSection>
-[[Category: Coagulation factor XIa]]
+[[Category: Homo sapiens]]
-[[Category: Akkaya, S]]
+[[Category: Large Structures]]
-[[Category: Beisel, H G]]
+[[Category: Akkaya S]]
-[[Category: Eriksson, P O]]
+[[Category: Beisel HG]]
-[[Category: Erixon, K]]
+[[Category: Eriksson PO]]
-[[Category: Fjellstrom, O]]
+[[Category: Erixon K]]
-[[Category: Gustafsson, D]]
+[[Category: Fjellstrom O]]
-[[Category: Jurva, U]]
+[[Category: Gustafsson D]]
-[[Category: Kang, D]]
+[[Category: Jurva U]]
-[[Category: Karis, D]]
+[[Category: Kang D]]
-[[Category: Knecht, W]]
+[[Category: Karis D]]
-[[Category: Nerme, V]]
+[[Category: Knecht W]]
-[[Category: Nilsson, I]]
+[[Category: Nerme V]]
-[[Category: Olsson, T]]
+[[Category: Nilsson I]]
-[[Category: Oster, L]]
+[[Category: Olsson T]]
-[[Category: Redzic, A]]
+[[Category: Oster L]]
-[[Category: Roth, R]]
+[[Category: Redzic A]]
-[[Category: Sandmark, J]]
+[[Category: Roth R]]
-[[Category: Tigerstrom, A]]
+[[Category: Sandmark J]]
-[[Category: Hydrolase]]
+[[Category: Tigerstrom A]]